When combined, chromatography and mass spectrometry ensure high data reproducibility and high throughput. The analyses can be applied to all types of biosimilar products, where the active pharmaceutical ingredient (API) is protein. Examples include monoclonal antibodies, Fc-fusion proteins, interleukins and other cytokines, and recombinant proteins like insulin and erythropoietin.